Watch your calendars for May 18.
That’s the date by which a Federal Trade Commission administrative law judge says he’ll issue his ruling in a pay-for-delay case involving allegations generic drugmaker Impax Laboratories Inc. accepted more than $100 million to delay its release of a generic version of Endo Pharmaceuticals Inc.’s opioid pain medication, Opana ER.
The ALJ’s ruling could potentially jump-start more FTC enforcement actions against drug companies for anticompetitive conduct.
The Impax case is the FTC’s latest effort to crack down on “pay-for-delay” or “reverse payment” deals in which brand-name drugmakers pay their generic competitors to keep cheaper alternatives off the market for a period of time.
And the ruling could help shed light on unsettled areas of antitrust law, including what constitutes a “large payment” that would violate antitrust laws.
Other than a pharmaceutical antitrust action brought by private party litigants over a reverse payment deal over the drug Nexium, the Impax case is the only other reverse payment case that’s gone to trial since 2017.
Meanwhile, the FTC will require Impax to divest its rights and assets to 10 generic drug products as a condition for drugmaker Amneal Pharmaceuticals LLC’s acquiring a $1.45 billion equity stake in Impax.
Read my article here.
Stay on top of new developments in health law and regulation, and learn more, by signing up for a free trial to Bloomberg Law.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)